These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20621945)

  • 41. The cognitive burden of multiple sclerosis in children.
    Banwell BL; Anderson PE
    Neurology; 2005 Mar; 64(5):891-4. PubMed ID: 15753431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disease progression in pediatric multiple sclerosis: disparities between physical and neurocognitive outcomes.
    Yeh EA; Parrish JB; Weinstock-Guttman B
    Expert Rev Neurother; 2011 Mar; 11(3):433-40. PubMed ID: 21375448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
    Doody RS; Ferris SH; Salloway S; Sun Y; Goldman R; Watkins WE; Xu Y; Murthy AK
    Neurology; 2009 May; 72(18):1555-61. PubMed ID: 19176895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropsychological rehabilitation has beneficial effects on perceived cognitive deficits in multiple sclerosis during nine-month follow-up.
    Rosti-Otajärvi E; Mäntynen A; Koivisto K; Huhtala H; Hämäläinen P
    J Neurol Sci; 2013 Nov; 334(1-2):154-60. PubMed ID: 24011606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism.
    Oertel H; Schneider HJ; Stalla GK; Holsboer F; Zihl J
    Psychoneuroendocrinology; 2004 Aug; 29(7):839-50. PubMed ID: 15177699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rehabilitation of traumatic brain injury in active duty military personnel and veterans: Defense and Veterans Brain Injury Center randomized controlled trial of two rehabilitation approaches.
    Vanderploeg RD; Schwab K; Walker WC; Fraser JA; Sigford BJ; Date ES; Scott SG; Curtiss G; Salazar AM; Warden DL;
    Arch Phys Med Rehabil; 2008 Dec; 89(12):2227-38. PubMed ID: 19061734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cognitive rehabilitation in multiple sclerosis: a randomized controlled trial.
    Hanssen KT; Beiske AG; Landrø NI; Hofoss D; Hessen E
    Acta Neurol Scand; 2016 Jan; 133(1):30-40. PubMed ID: 25952561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: a double blind, placebo-controlled study.
    Young JL
    Psychiatry Res; 2013 May; 207(1-2):127-33. PubMed ID: 23062791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancing effect of HT008-1 on cognitive function and quality of life in cognitively declined healthy adults: a randomized, double-blind, placebo-controlled, trial.
    Kim J; Chung SY; Park S; Park JH; Byun S; Hwang M; Oh DS; Choi H; Kim MY; Bu YC; Doré S; Whang WW; Kim H
    Pharmacol Biochem Behav; 2008 Oct; 90(4):517-24. PubMed ID: 18550156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Audio Recorded Cognitive Screen (ARCS) in patients with multiple sclerosis: a practical tool for multiple sclerosis clinics.
    Lechner-Scott J; Kerr T; Spencer B; Agland S; Lydon A; Schofield PW
    Mult Scler; 2010 Sep; 16(9):1126-33. PubMed ID: 20621944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of psychiatric co-morbidity on cognitive functioning in a population-based sample of depressed young adults.
    Castaneda AE; Marttunen M; Suvisaari J; Perälä J; Saarni SI; Aalto-Setälä T; Aro H; Lönnqvist J; Tuulio-Henriksson A
    Psychol Med; 2010 Jan; 40(1):29-39. PubMed ID: 19413917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized, controlled, single-blind, 6-month pilot study to evaluate the efficacy of MS-Line!: a cognitive rehabilitation programme for patients with multiple sclerosis.
    Gich J; Freixanet J; García R; Vilanova JC; Genís D; Silva Y; Montalban X; Ramió-Torrentà L
    Mult Scler; 2015 Sep; 21(10):1332-43. PubMed ID: 25716880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of cognitive dysfunction on benefit from learning and memory rehabilitation in MS: A sub-analysis of the MEMREHAB trial.
    Chiaravalloti ND; DeLuca J
    Mult Scler; 2015 Oct; 21(12):1575-82. PubMed ID: 25662348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computer-assisted cognitive rehabilitation of attention deficits for multiple sclerosis: a randomized trial with fMRI correlates.
    Cerasa A; Gioia MC; Valentino P; Nisticò R; Chiriaco C; Pirritano D; Tomaiuolo F; Mangone G; Trotta M; Talarico T; Bilotti G; Quattrone A
    Neurorehabil Neural Repair; 2013 May; 27(4):284-95. PubMed ID: 23192417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of executive functions and memory on self-generation benefit in persons with multiple sclerosis.
    Goverover Y; Chiaravalloti N; DeLuca J
    J Clin Exp Neuropsychol; 2013; 35(7):775-83. PubMed ID: 23957817
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors and impact of the working alliance in the neuropsychological rehabilitation of patients with multiple sclerosis.
    Rosti-Otajärvi E; Mäntynen A; Koivisto K; Huhtala H; Hämäläinen P
    J Neurol Sci; 2014 Mar; 338(1-2):156-61. PubMed ID: 24433929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term effectiveness of combined cognitive-behavioral and neuropsychological intervention in a case of multiple sclerosis.
    Martínez-González AE; Piqueras JA
    Neurocase; 2015; 21(5):584-91. PubMed ID: 25330097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Who benefits from treatment for executive dysfunction after brain injury? Negative effects of emotion recognition deficits.
    Spikman JM; Boelen DH; Pijnenborg GH; Timmerman ME; van der Naalt J; Fasotti L
    Neuropsychol Rehabil; 2013; 23(6):824-45. PubMed ID: 23964996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Magnetic resonance imaging predictors of executive functioning in patients with pediatric-onset multiple sclerosis.
    Till C; Ho C; Dudani A; García-Lorenzo D; Collins DL; Banwell BL
    Arch Clin Neuropsychol; 2012 Aug; 27(5):495-509. PubMed ID: 22751624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.